Magnolol triggers ferroptosis in triple-negative breast cancer through modulation of the ETS2/SLC7A11/GPX4 signaling axis

Jing Zhu, Ke Zhong, Yan Zhuang, Ao Cai, Yu-Han Zhou, Jie Yuan, Feng Ding, Long Zhao, Yu-Xin Zhang, Bo-Han Li, Cheng-Zhu Wu, Hong-Mei Li

Open source

DOI
10.3389/fphar.2026.1876648
Published
2026-07-31
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1876648,
  title = {Magnolol triggers ferroptosis in triple-negative breast cancer through modulation of the ETS2/SLC7A11/GPX4 signaling axis},
  author = {Jing Zhu and Ke Zhong and Yan Zhuang and Ao Cai and Yu-Han Zhou and Jie Yuan and Feng Ding and Long Zhao and Yu-Xin Zhang and Bo-Han Li and Cheng-Zhu Wu and Hong-Mei Li},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1876648},
  url = {https://doi.org/10.3389/fphar.2026.1876648}
}

RIS

TY  - JOUR
TI  - Magnolol triggers ferroptosis in triple-negative breast cancer through modulation of the ETS2/SLC7A11/GPX4 signaling axis
AU  - Jing Zhu
AU  - Ke Zhong
AU  - Yan Zhuang
AU  - Ao Cai
AU  - Yu-Han Zhou
AU  - Jie Yuan
AU  - Feng Ding
AU  - Long Zhao
AU  - Yu-Xin Zhang
AU  - Bo-Han Li
AU  - Cheng-Zhu Wu
AU  - Hong-Mei Li
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1876648
UR  - https://doi.org/10.3389/fphar.2026.1876648
ER  - 

APA

Zhu, J., Zhong, K., Zhuang, Y., Cai, A., Zhou, Y., Yuan, J., Ding, F., Zhao, L., Zhang, Y., Li, B., Wu, C., & Li, H. (2026). Magnolol triggers ferroptosis in triple-negative breast cancer through modulation of the ETS2/SLC7A11/GPX4 signaling axis. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1876648

Source records